Transparency Reporting

Doctors, pharmacists, nurses, healthcare institutions and organisations, and patient organisations regularly collaborate with pharmaceutical companies such as Gilead. This leads to new and better drugs and treatment methods, and to a better understanding of patients' needs. Sometimes these healthcare providers, healthcare institutions and patient organisations receive compensation for their cooperation or receive financial support for their projects.

For transparency purposes and pursuant to applicable laws and / or ethic rules, Gilead will disclose on the appropriate platform the transfers of value made to reportable recipients (HCPs, HCOs, and / or Patient Organizations) including the name, amount, and nature of the transfer of value and any other required information. Transfers of value granted in the framework of scientific research (R&D) are on an aggregated basis.

Inquiries about the disclosed transfers of value should be directed to Netherlands.Transparency@gilead.com (for Dutch recipients) or Belgium.Transparency@gilead.com (for Belgian and Luxembourgish recipients).

The Netherlands

Please consult Transparantieregister Zorg

The costs of R&D (research and development) are not included in the Dutch transparency register, but are published here on this page. The amount paid in 2024 is € 11.097.495,50.

Belgium

For transparency purposes and pursuant to applicable law, Gilead will disclose transfers of value made to HCPs, HCOs and Patient Organizations based in Belgium on www.betransparent.be, including the name, amount and nature of the transfer of value and any other required information. Transfers of value granted in the framework of scientific research are disclosed on www.betransparent.be on an aggregated basis.

Inquiries about the disclosed transfers of value should be directed to public_affairs@gilead.com.

Luxembourg

For transparency purposes and in accordance with the applicable laws and/or ethics rules, Gilead will disclose transfers of value made to HCPs, HCOs and Patient Organizations based in Luxembourg on the appropriate platform, including the name, amount and nature of the transfer of value and any other required information.

The disclosure reports for Luxembourg may be consulted below: